Ernexa Therapeutics Inc. Other Non-Current Assets
Ernexa Therapeutics Inc. (ERNA) had Other Non-Current Assets of $25.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:OtherAssetsNoncurrent · last filed 2026-08-06
- 2026-06-30: Other Assets, Noncurrent $25.00K.
- 2026-03-31: Other Assets, Noncurrent $110.00K.
- 2025-12-31: Other Assets, Noncurrent $110.00K.
- 2025-09-30: Other Assets, Noncurrent $116.00K.
| Period end | Other Assets, Noncurrent |
|---|---|
| 2026-06-30 | $25.00K 10-Q · filed 2026-08-06 |
| 2026-03-31 | $110.00K 10-Q · filed 2026-05-11 |
| 2025-12-31 | $110.00K 10-Q · filed 2026-08-06 |
| 2025-09-30 | $116.00K 10-Q · filed 2025-11-07 |
| 2025-06-30 | $117.00K 10-Q · filed 2025-08-13 |
| 2025-03-31 | $118.00K 10-Q · filed 2025-05-07 |
| 2024-12-31 | $118.00K 10-K · filed 2026-03-13 |
| 2024-09-30 | $120.00K 10-Q · filed 2024-11-12 |
| 2024-06-30 | $120.00K 10-Q · filed 2024-08-13 |
| 2024-03-31 | $120.00K 10-Q · filed 2024-05-14 |
| 2023-12-31 | $120.00K 10-K · filed 2025-03-12 |
| 2023-09-30 | $4.04M 10-Q · filed 2023-11-13 |
| 2023-06-30 | $1.37M 10-Q · filed 2023-08-11 |
| 2023-03-31 | $1.24M 10-Q · filed 2023-05-11 |
| 2022-12-31 | $1.13M 10-K · filed 2024-03-14 |
| 2022-09-30 | $819.00K 10-Q · filed 2022-11-14 |
| 2021-12-31 | $488.00K 10-K · filed 2023-03-20 |
| 2020-12-31 | $50.00K 10-K · filed 2021-03-11 |
| 2020-09-30 | $62.00K 10-Q · filed 2020-11-13 |
| 2020-06-30 | $62.00K 10-Q · filed 2020-08-07 |
| 2020-03-31 | $120.00K 10-Q · filed 2020-05-20 |
| 2019-12-31 | $97.00K 10-K · filed 2021-03-11 |
| 2019-09-30 | $100.00K 10-Q · filed 2019-11-01 |
| 2019-06-30 | $100.00K 10-Q · filed 2019-08-12 |
| 2019-03-31 | $100.00K 10-Q · filed 2019-05-14 |
| 2018-12-31 | $103.00K 10-K · filed 2020-03-19 |
| 2018-09-30 | $84.00K 10-Q · filed 2018-11-09 |
| 2018-06-30 | $29.00K 10-Q · filed 2018-08-06 |
| 2018-03-31 | $34.00K 10-Q · filed 2018-05-11 |
| 2017-12-31 | $16.00K 10-K · filed 2019-03-22 |
| 2017-09-30 | $87.00K 10-Q · filed 2017-11-08 |
| 2017-06-30 | $100.00K 10-Q · filed 2017-08-04 |
| 2017-03-31 | $110.00K 10-Q · filed 2017-05-04 |
| 2016-12-31 | $92.00K 10-K · filed 2018-03-09 |
| 2016-09-30 | $100.00K 10-Q · filed 2016-11-09 |
| 2016-06-30 | $102.00K 10-Q · filed 2016-08-04 |
| 2016-03-31 | $119.00K 10-Q · filed 2016-05-09 |
| 2015-12-31 | $124.00K 10-K · filed 2017-03-09 |
| 2015-09-30 | $133.00K 10-Q · filed 2015-11-09 |
| 2015-06-30 | $149.00K 10-Q · filed 2015-08-10 |
| 2015-03-31 | $57.00K 10-Q · filed 2015-05-08 |
| 2014-12-31 | $57.00K 10-K · filed 2016-03-15 |
| 2014-09-30 | $86.00K 10-Q · filed 2014-11-07 |
| 2014-06-30 | $84.00K 10-Q · filed 2014-08-14 |
| 2014-03-31 | $85.00K 10-Q · filed 2014-05-15 |
| 2013-12-31 | $84.00K 10-K · filed 2015-03-27 |
| 2013-09-30 | $310.00K 10-Q · filed 2013-11-14 |
| 2013-06-30 | $307.00K 10-Q · filed 2013-08-14 |
| 2013-03-31 | $298.00K 10-Q · filed 2013-05-13 |
| 2012-12-31 | $220.00K 10-K · filed 2014-03-31 |
| 2012-09-30 | $53.00K 10-Q · filed 2012-11-09 |
| 2012-06-30 | $59.00K 10-Q · filed 2012-08-14 |
| 2012-03-31 | $64.00K 10-Q · filed 2012-05-11 |
| 2011-12-31 | $61.00K 10-K · filed 2013-03-29 |
| 2011-09-30 | $89.00K 10-Q · filed 2011-11-14 |
| 2011-06-30 | $89.00K 10-Q · filed 2011-08-12 |
| 2010-12-31 | $41.00K 10-K · filed 2012-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| SYNLOGIC, INC. (SYBX) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B |